Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!

Notizia

Feb 26, 2019

Table of Contents

Vertex, CRISPR Therapeutics treated a patient using CRISPR

In the very first, a patient diagnosed with Beta thalassemia was treated using CRISPR gene editing tool by Vertex and CRISPR Therapeutics. CTX001 used to treat the disease, was extracted from hematopoietic stem cells from patients, engineered ex vivo using cas-9. The use of cas-9 to produce high levels of fetal hemoglobin in red blood cells will help to lessen down the need for blood transfusion.

Cures for Dry Eyes ahead

Dry eyes result in loss of goblet cells,glycocalyx mucin and corneal and conjunctival epithelial cell damage’ referred to as hyperosmolarity-triggered inflammatory cascade. In a recent report, authored by Maria Markoulli and Alex Hui, the cure published is the management of dry eyes to further prevent homeostasis of the tear film and end the hyperosmolarity-triggered inflammatory cascade.

Downloads

Article in PDF

Recent Articles

Japan has got new ways to treat corneas

FDA declines the approval of Lipocine’s testosterone drug; Novartis Sandoz to buy Aspen Pharmaca...

Sleep Disorders: An Emerging Public Health Issue

CRISPR proves to be a blessing for LASSA fever

How Gene therapy is changing the Beta-thalassemia Treatment outlook?

Bone marrow transfer helps to avert Cognitive Impairment

Recent research confirms that the transfer of bone marrow from a new mouse into an old one slows down the aging of the later. The transfer resulted in safeguarding their memories and retaining learning abilities.

It is not your thoughts but your genes behind sleep deprivation

In a new discovery, Scientists at Massachusetts General Hospital (MGH) and the University of Exeter Medical School have identified 57 gene loci which are related to sleeplessness. Study of gene locations associated with Insomnia can help in finding cures. Because as of now the treatments available are not that effective.